Vertero Therapeutics
PrivateLast Round
Series D
Oct 21, 2025
Total Funding Raised
$111.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vertero Therapeutics is a biotechnology company that develops oral small-molecule therapeutics targeting peripheral nervous system drivers of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vertero Therapeutics Comparables
Compare Vertero Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterin | 86% | |
| Stellate Therapeutics Inc. | 82% | |
| Kallyope | 81% | |
Vertero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 21, 2025 | ||||
| Grant | Jun 20, 2023 | ||||
| Series C | Oct 13, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Series B Extension | Jun 20, 2019 | ||||
Series B | Feb 27, 2019 |
Key People
Founding team and executive leadership
Vertero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series D, Series C |
| Domain Associates | Series B, Series C, Series A |
| Kairos Ventures | Series A |
| Taiho Ventures | Series C, Series B Extension |
| Kairos Ventures | Series A |
| Corundum Systems Biology | Series C |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1556% MoM.
- Oct 21, 2025
$20M round led by OneVentures and Seventure Partners.
Vertero Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vertero Therapeutics's valuation, stock price, and market status.